These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21135597)

  • 1. Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia.
    Wolf A; McGoldrick KE
    Cardiol Rev; 2011; 19(1):12-6. PubMed ID: 21135597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic considerations in anesthesia.
    Goldstein S; Amar D
    Heart Dis; 2003; 5(1):34-48. PubMed ID: 12549987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith I; Jackson I
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk, drugs and erectile function--a systematic analysis.
    Baumhäkel M; Schlimmer N; Kratz M; Hackett G; Jackson G; Böhm M
    Int J Clin Pract; 2011 Mar; 65(3):289-98. PubMed ID: 21314866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac medication in the perioperative period.
    Wallner T; Preis C; Mayer N
    Acta Anaesthesiol Scand Suppl; 1997; 111():22-8. PubMed ID: 9420942
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular therapies and risk for development of diabetes.
    Pepine CJ; Cooper-Dehoff RM
    J Am Coll Cardiol; 2004 Aug; 44(3):509-12. PubMed ID: 15358012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.
    Davis EM; Packard KA; Hilleman DE
    Pharmacotherapy; 2010 Jul; 30(7):749, 274e-318e. PubMed ID: 20575638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs used in cardiovascular diseases and cytokines].
    Andrzejczak D; Górska D
    Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential oral manifestations of cardiovascular drugs.
    Habbab KM; Moles DR; Porter SR
    Oral Dis; 2010 Nov; 16(8):769-73. PubMed ID: 20604876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in cardiovascular pharmacology].
    Zhu JR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Dec; 21(6):358-60. PubMed ID: 7913889
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
    Castelino RL; Chen TF; Guddattu V; Bajorek BV
    Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of restrictive prescription plans on heart failure medication use.
    Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
    Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.